Nitric oxide (NO) synthesis is markedly augmented in states of inflammation
, largely due to the expression of inducible nitric oxide synthase (iNOS).
Although NO has anti-inflammatory consequences under basal conditions, it r
emains enigmatic as to why NO displays proinflammatory characteristics in c
hronic inflammation. Either the antiinflammatory actions are weak and of li
ttle consequence or, alternatively, other factors influence the role of NO
in chronic inflammation. We propose that the answer to this enigma lies in
the conversion of NO to other higher oxides of nitrogen (NO2, nitrogen diox
ide; N2O3, dinitrogen trioxide; and ONOO-, peroxynitrite). Emerging therape
utic strategies may be independent of NO synthesis; e.g., antioxidants have
no direct interaction with NO but attenuate the levels and activity of hig
her nitrogen oxides. Thus, whereas iNOS may be a marker for the proinflamma
tory actions of NO, the species that mediate tissue injury/dysfunction in i
nflammation are likely to be nitrogen oxides other than NO,